tiprankstipranks
Trending News
More News >
Response Genetics (RGDXQ)
OTHER OTC:RGDXQ
US Market
Advertisement

Response Genetics (RGDXQ) Financial Statements

Compare
8 Followers

Response Genetics Financial Overview

Response Genetics's market cap is currently $39.00. The company's EPS TTM is $; its P/E ratio is ―; Response Genetics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 15Dec 14Dec 13Dec 12Dec 11
Currency in USD

Response Genetics Earnings and Revenue History

Response Genetics Debt to Assets

Response Genetics Cash Flow

Response Genetics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis